CAGNONI PABLO J

CIK 00012057037 companiesWILMINGTON, DE

SEC Profile

Transactions

Companies

Filings

CIK

0001205703

Recent Transactions

50 trades

Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2026-01-16+28,475→ 28,475 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2025-07-15+39,471→ 39,471 total
Award
INCYTE CORP$INCY
Common Stock
2025-07-15+17,538→ 234,800 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2025-07-15$68.25/sh−2,628→ 217,262 total
Award
INCYTE CORP$INCY
Performance Shares
2025-07-15+43,846→ 43,846 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2025-07-14$69.98/sh−1,280→ 219,890 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2025-01-17+40,289→ 40,289 total
Award
INCYTE CORP$INCY
Common Stock
2024-07-15+19,851→ 221,919 total
Tax Payment
INCYTE CORP$INCY
Common Stock
2024-07-15$64.25/sh−749→ 221,170 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2024-07-15+44,411→ 44,411 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−30,000→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−141,011→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−17,000→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−17,000→ 0 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−17,000→ 0 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2024-01-18+21,843→ 21,843 total
Award
INCYTE CORP$INCY
Common Stock
2023-07-14+9,668→ 202,068 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2023-07-14+20,275→ 20,275 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2023-06-14+17,000→ 17,000 total
Award
INCYTE CORP$INCY
Common Stock
2023-06-05+179,613→ 179,613 total
Award
INCYTE CORP$INCY
Common Stock
2023-06-05+192,400→ 192,400 total
Sale
Rubius Therapeutics, Inc.
Common Stock
2023-02-01$0.25/sh−8,448→ 66,082 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Restricted Stock Units
2023-01-31−25,000→ 75,000 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Common Stock
2023-01-31+25,000→ 81,770 total
Sale
Rubius Therapeutics, Inc.
Common Stock
2023-01-31$0.24/sh−7,240→ 74,530 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Restricted Stock Units
2023-01-29−21,250→ 42,500 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Common Stock
2023-01-29+21,250→ 56,770 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2022-06-14+17,000→ 17,000 total
Sale
Rubius Therapeutics, Inc.
Common Stock
2022-02-01$6.57/sh−6,730→ 35,520 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2022-01-31+365,000→ 365,000 total
Award
Rubius Therapeutics, Inc.
Restricted Stock Units
2022-01-31+100,000→ 100,000 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Common Stock
2022-01-29+21,250→ 42,250 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Restricted Stock Units
2022-01-29−21,250→ 63,750 total
Gift
Rubius Therapeutics, Inc.
Common Stock
2021-06-16−2,200→ 29,320 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2021-06-04+17,000→ 17,000 total
Gift
Rubius Therapeutics, Inc.
Common Stock
2021-04-26−4,000→ 31,520 total
Award
Rubius Therapeutics, Inc.
Restricted Stock Units
2021-01-29+85,000→ 85,000 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-29+375,000→ 375,000 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2020-06-25+30,000→ 30,000 total
Purchase
Rubius Therapeutics, Inc.
Common Stock
2020-04-14$4.70/sh+21,000→ 21,000 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-31+500,000→ 500,000 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2019-11-19$62.00/sh−7,500→ 0 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2019-11-19$5.59/sh+7,500→ 7,500 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2019-11-19−7,500→ 63,833 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2019-11-12−7,500→ 71,333 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2019-11-12$55.00/sh−7,500→ 0 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2019-11-12$5.59/sh+7,500→ 7,500 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2019-10-30$5.59/sh+7,500→ 7,500 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2019-10-30$52.00/sh−7,500→ 0 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2019-10-30−7,500→ 78,833 total

Companies

Recent Filings

Address

1801 AUGUSTINE CUT-OFF

WILMINGTON, DE, 19083

View on SEC.gov